UPC Case Law
Meril GmbH v SWAT Medical AB and another
Order of the UPC Court of Appeal of 12 February 2025, UPC CoA 635/2024
UPC Case Law by Pitch, edited by Bart Lieben · Published
TL;DR
A lawyer or European Patent Attorney who is personally a party before the UPC must still be represented by someone else. A chair of a company's board cannot represent that company. The Court of Appeal gave both applicants for register access 14 days to instruct an authorised representative and file a Statement of response. The order closes the self-representation route for qualified practitioners and confirms that the Court may examine representation of its own motion at any stage.
Key holding
Under R 8.1 RoP, lawyers and European Patent Attorneys are not exempt from the duty to be represented when they are themselves parties in proceedings before the UPC. Representation is a point of admissibility involving public policy (due process), which the Court may examine at any time, including of its own motion. A natural person holding a high-level management position in a legal person, such as chair of its board of directors, cannot represent that legal person, even if qualified under Art 48(1) or (2) UPCA.
Questions decided
- Can a European Patent Attorney who is a party represent himself before the UPC?
- May the Court of Appeal examine representation of its own motion at any stage?
- Can the chair of a company's board represent that company before the UPC?
- Is an inadmissibility objection raised for the first time late in the appeal admissible?
- What follows when a party is found to be unrepresented on appeal?
Full summary
Read the full analyses for free — create a free account
With a free Academy account you read the full analysis of every Court of Appeal decision: the facts and procedure, the issues, the court’s reasoning and the practice points. Your name, an e-mail address and a password; no payment, and you can delete the account yourself at any time.
In the same case
- Decision · UPC CoA 464/2024
Meril Italy Srl and others v Edwards Lifesciences Corporation
The Court of Appeal upheld EP 3 646 825 as amended by Auxiliary Request II and confirmed that Meril's Myval Octacor heart valve system infringes it.
- Decision · UPC CoA 635/2024
Meril GmbH v Respondent 1 and SWAT Medical AB
The Court of Appeal set aside a Paris Central Division order that had given a European patent attorney and his company access to all pleadings and evidence in a revocation counterclaim.
- Order · UPC CoA 166/2025
Meril GmbH and others v Edwards Lifesciences Corporation
The Court of Appeal refused Meril's request to suspend the Munich Local Division's infringement decision in favour of Edwards Lifesciences pending Meril's appeal.
- Order · UPC CoA 636/2024
Meril Life Sciences Pvt. Ltd v Respondent 1 and SWAT Medical AB
A lawyer or European Patent Attorney who is a party before the UPC cannot represent himself and must instruct a separate authorised representative.
More on procedure
- Decision · UPC CoA 163/2026
PAUSTIAN & PARTNER Patentanwälte mbB v NUC Electronics Europe GmbH and others
The Court of Appeal granted a patent law firm access to the statements of appeal and statements of grounds of appeal in three closed appeals concerning EP 2 028 981.
- Order · UPC CoA 133/2026
The Walt Disney Company and others v InterDigital VC Holdings, Inc.
A request under R 262A RoP to stop the other party from accessing or using confidential information cannot be made for the first time on appeal for material already filed at first instance.
- Decision · UPC CoA 49/2026
Guardant Health, Inc. v Sophia Genetics SA and others
The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.